RCAMU
AMAG

Rothschild & Co Asset Management US’s AMAG Pharmaceuticals AMAG Stock Holding History

Rothschild & Co Asset Management US’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-40,132
Closed -$738K – 568
2017
Q2 		$738K Sell
40,132
-1,812
-4% -$35.9K 0.01% 400
2017
Q1 		$946K Sell
41,944
-3,102
-7% -$74.3K 0.01% 373
2016
Q4 		$1.57M Buy
45,046
+35,360
+365% +$1.06M 0.02% 354
2016
Q3 		$237K Buy
9,686
+244
+3% +$6.1K ﹤0.01% 523
2016
Q2 		$226K Sell
9,442
-299,723
-97% -$6.87M ﹤0.01% 551
2016
Q1 		$7.23M Buy
309,165
+5,073
+2% +$120K 0.14% 222
2015
Q4 		$9.18M Buy
304,092
+15,539
+5% +$502K 0.17% 196
2015
Q3 		$11.5M Buy
288,553
+162,668
+129% +$10.1M 0.22% 156
2015
Q2 		$8.69M Buy
125,885
+1,240
+1% +$78K 0.16% 211
2015
Q1 		$6.81M Buy
124,645
+31,657
+34% +$1.51M 0.13% 235
2014
Q4 		$3.96M Buy
92,988
+173
+0.2% +$6.25K 0.08% 276
2014
Q3 		$2.96M Sell
92,815
-3,680
-4% -$78.5K 0.06% 300
2014
Q2 		$2M Hold
96,495
– – 0.04% 326
2014
Q1 		$1.87M Sell
96,495
-44,812
-32% -$952K 0.04% 337
2013
Q4 		$3.43M Buy
141,307
+27,258
+24% +$641K 0.08% 310
2013
Q3 		$2.45M Sell
114,049
-20,006
-15% -$473K 0.05% 323
2013
Q2 		$2.98M Buy
+134,055
New +$2.95M 0.07% 315

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Rothschild & Co Asset Management US's AMAG Position: Q3 2017 in Review

Rothschild & Co Asset Management US sold out of AMAG Pharmaceuticals (AMAG) in Q3 2017, closing a stake of 40,132 shares — an estimated $738K sold.

Rothschild & Co Asset Management US first reported a position in AMAG in Q2 2013 and held it in 17 quarters. The position peaked at $11.5M in Q3 2015. 187 funds tracked by Wall St. Rank hold AMAG as of Q3 2017.

  • Rothschild & Co Asset Management US reported no remaining AMAG Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 40,132 AMAG Pharmaceuticals shares in Q3 2017, an estimated $738K.
  • Rothschild & Co Asset Management US first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Rothschild & Co Asset Management US's AMAG Pharmaceuticals position peaked at $11.5M in Q3 2015.
  • 187 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2017.

Based on Rothschild & Co Asset Management US's 13F filing for Q3 2017, filed 8 Nov 2017.